600
Participants
Start Date
August 13, 2012
Primary Completion Date
June 30, 2017
Study Completion Date
July 12, 2018
No Intervention
All treatment options (inc. surgery, TACE, drugs) will be registered.
Multiple Locations
Lead Sponsor
Bayer
INDUSTRY